文献速递衰弱、肌少症与跌倒多重用药

AFRAID与FRIGHT时钟在新型临床前多重用药小鼠模型中的应用

Applying the AFRAID and FRIGHT Clocks to Novel Preclinical Mouse Models of Polypharmacy.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2022-01-01

研究在雄性C57BL/6J小鼠中评估FRIGHT和AFRAID时钟在多重用药(≥5种药物)背景下的效用;从12月龄开始给予对照、多重用药或单药治疗,21月龄时部分撤药;结果各持续治疗组与对照组的AFRAID、FRIGHT、衰弱指数和死亡年龄无差异,FRIGHT和衰弱指数与死亡率相关而AFRAID不相关,AFRAID预测死亡率的偏倚和精度因治疗组而异。

要点

  • 持续多重用药或单药治疗未改变AFRAID、FRIGHT、衰弱指数及死亡年龄。
  • FRIGHT和衰弱指数与死亡率相关,AFRAID与死亡率不相关。
  • AFRAID预测死亡率的偏倚和精度因治疗组不同,部分撤药影响体重等成分。

核心结论

  • 在该队列中,FRIGHT和AFRAID未识别出治疗效应,撤药效应有限,对死亡率的预测表现不一。

研究设计与样本

  • 雄性C57BL/6J(B6)小鼠从12月龄起接受对照、多重用药或单药治疗,21月龄时各组再分为继续治疗或撤药亚组。
  • 基于衰弱指数计算AFRAID和FRIGHT时钟,比较治疗组间时钟差异并分析其与死亡率的相关性。

主要发现

  • 继续治疗各组与对照组之间AFRAID、FRIGHT、衰弱指数和死亡年龄均无差异。
  • 与继续治疗相比,撤除某些治疗对部分时钟和死亡率有不一致的负面影响。
  • FRIGHT和衰弱指数与死亡率相关,而AFRAID与死亡率不相关。
  • AFRAID作为死亡率预测指标的偏倚和精度因治疗组而异。
  • 撤除某些药物对时钟成分(尤其是体重下降)的影响导致了偏倚。

临床怎么用

  • 在多重用药小鼠模型中解读FRIGHT和AFRAID时钟时需考虑治疗背景,特定干预效应可能引入偏倚。

局限性

  • 该队列中治疗对衰弱或死亡率影响极少,限制了对撤药效应的评估。
  • AFRAID预测死亡率的偏倚和精度因治疗组而异,需未来研究优化以减少特定干预效应带来的偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Frailty Inferred Geriatric Health Timeline (FRIGHT) and Analysis of Frailty and Death (AFRAID) clocks were developed to predict biological age and lifespan, respectively, in mice. Their utility within the context of polypharmacy (≥5 medications), which is very common in older adults, is unknown. In male C57BL/6J(B6) mice administered chronic polypharmacy, monotherapy, and undergoing treatment cessation (deprescribing), we aimed to compare these clocks between treatment groups; investigate whether treatment affected correlation of these clocks with mortality; and explore factors that may explain variation in predictive performance. Treatment (control, polypharmacy, or monotherapy) commenced from age 12 months. At age 21 months, each treatment group was subdivided to continue treatment or have it deprescribed. Frailty index was assessed and informed calculation of the clocks. AFRAID, FRIGHT, frailty index, and mortality age did not differ between continued treatment groups and control. Compared to continued treatment, deprescribing some treatments had inconsistent negative impacts on some clocks and mortality. FRIGHT and frailty index, but not AFRAID, were associated with mortality. The bias and precision of AFRAID as a predictor of mortality varied between treatment groups. Effects of deprescribing some drugs on elements of the clocks, particularly on weight loss, contributed to bias. Overall, in this cohort, FRIGHT and AFRAID measures identified no treatment effects and limited deprescribing effects (unsurprising as very few effects on frailty or mortality), with variable prediction of mortality. These clocks have utility, but context is important. Future work should refine them for intervention studies to reduce bias from specific intervention effects.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Mach J, Kane AE, Howlett SE, et al. Applying the AFRAID and FRIGHT Clocks to Novel Preclinical Mouse Models of Polypharmacy. J Gerontol A Biol Sci Med Sci. 2022. PMID: 35313348. doi:10.1093/gerona/glac067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。